Merck & Co., Inc.
MRK
$93.14
-$0.0494-0.05%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4,589.59% | 163.63% | 341.53% | -82.30% | -97.49% |
| Total Depreciation and Amortization | 13.75% | 9.09% | 5.69% | 0.35% | -1.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.05% | -67.62% | -91.01% | 242.50% | 211.40% |
| Change in Net Operating Assets | -66.30% | 38.13% | 55.03% | 38.33% | 20.74% |
| Cash from Operations | 65.06% | 6.25% | 10.71% | -5.84% | -31.89% |
| Capital Expenditure | 12.71% | 14.89% | 16.58% | 15.73% | 11.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 65.98% | 66.00% | 93.86% | -690.81% | -9,843.80% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.85% | 647.37% | 1,495.54% | 820.56% | 501.77% |
| Cash from Investing | 45.08% | 60.73% | 83.49% | -113.15% | -183.93% |
| Total Debt Issued | -39.40% | -39.40% | -78.99% | -- | -- |
| Total Debt Repaid | 26.50% | 56.99% | 72.57% | -150.00% | 22.03% |
| Issuance of Common Stock | 41.60% | -55.47% | -55.30% | -54.73% | -67.45% |
| Repurchase of Common Stock | 2.97% | -26.97% | -152.98% | -785.23% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.31% | -5.42% | -5.64% | -5.93% | -6.18% |
| Other Financing Activities | -13.41% | 15.27% | 10.63% | -49.08% | -36.67% |
| Cash from Financing | -46.20% | -52.17% | -217.87% | 31.12% | 47.25% |
| Foreign Exchange rate Adjustments | -1,373.91% | 28.08% | -267.31% | 24.63% | 105.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.29% | 330.61% | 240.09% | -451.11% | -227.31% |
